Incorrect Funding
In the published article, there was an error in the Funding statement. The Funding section misses the funding agency for AKP. The correct Funding statement appears below.
FUNDING
AOP acknowledges funding from the Dutch Medical Research Council (ZonMw), grant no. 09120011910035. CVL and OR acknowledge funding from the Belgian National Fund for Scientific Research (F.R.S-FNRS, Belgium); the French INSERM agency “ANRS/Maladies infectieuses émergentes”; the “Télévie” program of the F.R.S.-FNRS; ViiV Healthcare; the “Fondation Roi Baudouin”; the Internationale Brachet Stiftung (IBS); the Walloon Region (“Fonds de Maturation”); The “Amis des Instituts Pasteur à Bruxelles”, asbl.; the University of Brussels (ULB - Action de Recherche Concertée (ARC) grant); the NEAT (European AIDS Treatment Network) program; the University of Brussels (Action de Recherche Concertée ULB grant); the Marie Skłodowska-Curie COFUND action; and the European Union’s Horizon 2020 research and innovation program under grant agreement No 691119-EU4HIVCURE-H2020-MSCA-RISE-2015. CVL is “Directrice de Recherches” of the F.R.S-FNRS. The laboratory of CVL is part of the ULB-Cancer Research Centre (U-CRC) (Faculty of Medicine, ULB). AKP acknowledges funding from the National Science Centre, Poland (Sonata Bis Grant UMO2018/30/E/NZ1/00874).
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Statements
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Summary
Keywords
HIV-1, HIV-1 latency, HIV-1 reservoir, HIV-1 latency reversal, HIV-1 persistence
Citation
Pasternak AO, Rohr O, Van Lint C and Kula-Pacurar A (2023) Corrigendum: Editorial: The relevance of molecular mechanisms in HIV-1 latency and reactivation from latency. Front. Cell. Infect. Microbiol. 13:1213356. doi: 10.3389/fcimb.2023.1213356
Received
27 April 2023
Accepted
28 April 2023
Published
11 May 2023
Approved by
Frontiers Editorial Office, Frontiers Media SA, Switzerland
Volume
13 - 2023
Updates
Copyright
© 2023 Pasternak, Rohr, Van Lint and Kula-Pacurar.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Alexander O. Pasternak, a.o.pasternak@amsterdamumc.nl
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.